JASON EHRLICH - 20 Jul 2021 Form 4 Insider Report for Kodiak Sciences Inc. (KOD)

Role: Chief Medical Officer and Chief Development Officer
Signature: /s/ David Peinsipp, Attorney-in-Fact for Jason Ehrlich
Issuer symbol: KOD
Transactions as of: 20 Jul 2021
Net transactions value: -$599,624
Form type: 4
Filing time: 22 Jul 2021, 16:37:28 UTC
Previous filing: 23 Jun 2021
Next filing: 13 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KOD	Common Stock	Sale	$191,589	-2,234	-3.7%	$85.76^*	57,949	20 Jul 2021	Direct	F1, F2
transaction	KOD	Common Stock	Sale	$408,035	-4,716	-8.1%	$86.52^*	53,233	20 Jul 2021	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.
F2	The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $85.085 to $86.085, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
F3	The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $86.09 to $86.89, inclusive.

Remarks:

Chief Medical Officer and Chief Development Officer